Loading Events

Metabolic Health Summer Series: An Inside Look at Diabetes and Weight-Loss Medications

Obesity and other metabolic conditions are contributing to a significant increase in health issues worldwide. Many employers are now experiencing a sharp increase in utilization of anti-obesity medications, including GLP–1 drugs. Join the Brown & Brown Population Health & Well-Being team and our distinguished guest speakers in a three-part webinar series on strategies to help address metabolic health.

An Inside Look at Diabetes and Weight-Loss Medications

Wednesday, July 12, 2023 1:00 – 2:00 PM CDT
There is a newer class of medication used to treat diabetes and weight loss. These GLP-1 and combined GLP-1/GIP drugs are receiving a lot of media attention, leading to a shift in public and medical perception. Join us to learn about the similarities and differences between diabetes and weight loss medications, the impact of the media, pros and cons of these medications for weight loss and diabetes.


  • Austin Morgan, Pharm.D., BCACP, CDCES, Lead Clinical Pharmacist III – Development and Training, Tria Health
  • Andrea Grande, R.Ph., Principal, Brown & Brown



Sign up for the next two webinars in our summer series:


DISCLAIMER: Brown & Brown, Inc. and all its affiliates, do not provide legal, regulatory or tax guidance, or advice. If legal advice counsel or representation is needed, the services of a legal professional should be sought. The information in this document is intended to provide a general overview of the topics and services contained herein. Brown & Brown, Inc. and all its affiliates, make no representation or warranty as to the accuracy or completeness of the document and undertakes no obligation to update or revise the document based upon new information or future changes.

Date & Time

July 12, 2023
1:00 pm - 2:00 pm CDT


Positive young woman offering a bottle with medicine